SCM
CABA icon

Sterling Capital Management’s Cabaletta Bio CABA Stock Holding History

Sterling Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.1K Buy
+1,319
New +$4.34K ﹤0.01% 2728
2025
Q2 		– Sell
-636
Closed -$881 – 3283
2025
Q1 		$881 Sell
636
-543
-46% -$1.16K ﹤0.01% 2855
2024
Q4 		$2.68K Buy
1,179
+1,063
+916% +$3.73K ﹤0.01% 2699
2024
Q3 		$548 Buy
+116
New +$671 ﹤0.01% 2827

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Sterling Capital Management's CABA Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Cabaletta Bio (CABA) in Q2 2026: 1,319 shares worth $4.1K. The stake represents ﹤0.01% of the portfolio and ranks #2728 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in CABA as recently as Q1 2025.

Sterling Capital Management first reported a position in CABA in Q3 2024 and has held it in 4 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Sterling Capital Management held 1,319 shares of Cabaletta Bio worth $4.1K as of Q2 2026.
  • Cabaletta Bio was a new Sterling Capital Management position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2728 holding.
  • Sterling Capital Management first reported a position in Cabaletta Bio in Q3 2024 and has held it in 4 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.